The Ribavirin Pregnancy Registry (RPR)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00114712|
Recruitment Status : Recruiting
First Posted : June 17, 2005
Last Update Posted : March 16, 2018
Merck Sharp & Dohme Corp.
Teva Pharmaceuticals USA
Zydus Pharmaceuticals USA, Inc.
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Recruiting|
|Estimated Primary Completion Date :||December 2024|
|Estimated Study Completion Date :||December 2025|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):